SOLID BIOSCIENCES INC's ticker is SLDB and the CUSIP is 83422E105. A total of 108 filers reported holding SOLID BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $152,000 | -42.6% | 126,405 | -16.3% | 0.00% | – |
Q4 2021 | $265,000 | -26.6% | 150,937 | 0.0% | 0.00% | – |
Q3 2021 | $361,000 | -34.7% | 150,937 | 0.0% | 0.00% | – |
Q2 2021 | $553,000 | +39.3% | 150,937 | +110.6% | 0.00% | – |
Q1 2021 | $397,000 | -11.0% | 71,683 | +22.0% | 0.00% | – |
Q4 2020 | $446,000 | +309.2% | 58,747 | +10.3% | 0.00% | – |
Q3 2020 | $109,000 | -65.5% | 53,275 | -50.6% | 0.00% | – |
Q2 2020 | $316,000 | +47.7% | 107,808 | +20.9% | 0.00% | – |
Q1 2020 | $214,000 | -45.4% | 89,181 | +1.4% | 0.00% | – |
Q4 2019 | $392,000 | -59.6% | 87,908 | -6.2% | 0.00% | -100.0% |
Q3 2019 | $970,000 | +91.7% | 93,731 | +6.7% | 0.00% | – |
Q2 2019 | $506,000 | -15.1% | 87,843 | +35.7% | 0.00% | – |
Q1 2019 | $596,000 | -69.1% | 64,725 | -10.1% | 0.00% | -100.0% |
Q4 2018 | $1,930,000 | -44.7% | 72,001 | -2.6% | 0.00% | -50.0% |
Q3 2018 | $3,488,000 | +157.4% | 73,910 | +94.4% | 0.00% | +100.0% |
Q2 2018 | $1,355,000 | +409.4% | 38,011 | +7.5% | 0.00% | – |
Q1 2018 | $266,000 | – | 35,353 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 7,929,918 | $4,882,000 | 0.57% |
Perceptive Advisors | 13,412,552 | $8,257,000 | 0.26% |
Boxer Capital, LLC | 5,336,031 | $3,285,000 | 0.21% |
RA Capital Management | 12,367,873 | $7,614,000 | 0.20% |
K2 PRINCIPAL FUND, L.P. | 2,909,102 | $1,791,000 | 0.20% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,067,204 | $3,119,000 | 0.12% |
Artal Group S.A. | 3,000,000 | $1,847,000 | 0.10% |
Oasis Management Co Ltd. | 222,400 | $137,000 | 0.02% |
Quantum Private Wealth, LLC | 37,271 | $22,000 | 0.01% |
Laurion Capital Management LP | 1,156,600 | $712,000 | 0.01% |